why choose us

First received: June 14, 2023

Clinical Trial: Covid-19 Convalescent Plasma and Monoclonal Antibodies Treatment of Immunocompromised Patients

Study Status: Completed

Recruit Status: RECRUITING

Condition: COVID-19 Convalescent Plasma Treatment

Study Type: OBSERVATIONAL


Official Title: Analysis of the Efficacy and Tolerance of Covid-19 Convalescent Plasma and Monoclonal Antibodies in the Treatment of SARS-Cov2 Infections in Immunocompromised Patients

Brief Summary: Data on the use of convalescent plasma in the treatment of covid-19 are scarce: the results of randomized studies involving mainly immunocompetent patients are disappointing, while case series or retrospective data on more selected patients , in particular immunocompromised patients suggest a benefit in these patients whose clinical manifestation seems essentially related to the uncontrolled infection and not the cytokine storm.

Read more